Ahmed Khudhair
1, Marie E. Killerby
1
, Mariam Al Mulla, Kheir Abou Elkheir, Wassim Ternanni, Zyad Bandar, Stefan Weber, Mary Khoury, George Donnelly, Salama Al Muhairi, Abdelmalik I. Khalafalla, Suvang Trivedi, Azaibi Tamin, Natalie J. Thornburg, John T. Watson, Susan I. Gerber, Farida Al Hosani
2, and Aron J. Hall
2
Author affiliations: Abu Dhabi Department of Health, Abu Dhabi, United Arab Emirates (A. Khudhair, M. Al Mulla, K.A. Elkheir, W. Ternanni, Z. Bandar, F. Al Hosani); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.E. Killerby, S. Trivedi, A. Tamin, N.J. Thornburg, J.T. Watson, S.I. Gerber, A.J. Hall); Sheikh Khalifa Medical City, Abu Dhabi (S. Weber, M. Khoury, G. Donnelly); Abu Dhabi Food Control Authority, Abu Dhabi (S. Al Muhairi, A.I. Khalafalla)
Figure 2. Number of workers sampled during >1 round of sampling (N = 79), Abu Dhabi, United Arab Emirates. Black stars indicate when serum samples were taken; gray shading indicates follow-up periods.